Chimeric antigen receptor dendritic cells suppress melanoma growth in preclinical cancer models
Background
Chimeric antigen receptor (CAR)-T cell therapy has been successful for the treatment of hematological cancers but less effective against solid tumors, a phenomenon that results from the immunosuppressive nature of the tumor microenvironment…